The US contrast agents and radiopharmaceutical market was severely impacted by the COVID-19 pandemic in 2020, but has already shown significant recovery in 2021 and 2022; however, it continues to…
The COVID-19 pandemic negatively impacted the European contrast agents and radiopharmaceutical market in 2020. Following the recovery, growth in the European market will be supported by the…